Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: InvestingInChina	12/11/2007 9:14:43 AM
	Read Replies (1) of 78731

LTUS.OB (Lotus Pharma)is my pick with PE of 6. Fast growing Chinese pharma company specializing in generics, HQ in Beijing. Current ratio 3.2 * Already booked .13/share this year, expected to make .18/share for the year. * At today's price of about $1/share, the PE is 6 (!) * over 97% revenue growth in last report, and 123% income growth 2005-2006. State they expect that trend to continue in their recent investor presentation. * Working capital doubled to $15M in last Q report * Picked by Cheap Stocks blog as possibly the next AOB. (They picked AOB at about $1/share (now $12/share) and see similarities with LTUS' growth and business plans. cheapstockinvestor.blogspot.com LTUS investor presentation: yahoo.brand.edgar-online.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next